A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU

Clinical trial NCT03020992 · COMPLETED

Trial details

NCT number

NCT03020992

Sponsor

UCB Biopharma SRL

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2016-12-21

Primary completion

2019-12-04

Enrollment

89

View on ClinicalTrials.gov